| Authors: |
Arvanitaki A; National Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.; First Department of Cardiology, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece., Diller GP; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy's and St Thomas's NHS Foundation Trust, Imperial College, London, UK.; Department of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Muenster, Germany., Gatzoulis MA; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy's and St Thomas's NHS Foundation Trust, Imperial College, London, UK., McCabe C; National Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Price LC; National Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK Laura.price@rbht.nhs.uk.; National Heart and Lung Institute, Imperial College London, London, UK.; Both authors contributed equally., Wort SJ; National Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.; Both authors contributed equally. |
